All In MedTech

Device Trial Radar · NCT01796925

Targeted Hypoglossal Neurostimulation Study #2

Clinical Study of the aura6000™ Targeted Hypoglossal Implantable Neurostimulation (THN) Sleep Therapy System

Last checked: Nov 19, 2026Latest source record: Aug 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

57

Actual

Start

Feb 2013

Primary completion

Sep 2013

Study completion Sep 2014

Sponsor

Lead sponsor
ImThera Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Feb 22, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the study is to confirm the safety and efficacy in patients utilizing the aura6000 System for the treatment of Obstructive Sleep Apnea (OSA).

Conditions

  • Sleep Apnea Syndromes
  • Sleep Apnea, Obstructive
  • Respiration Disorders
  • Signs and Symptoms, Respiratory
  • Syndrome, Obstructive Sleep Apnea

Interventions

  • aura6000 THN SystemDevice

    The aura6000 device is an implanted hypoglossal nerve stimulator designed to maintain wakeful muscle tone of the tongue during sleep. It is implanted through a short surgical procedure. The implant is programmed to provide the optimal stimulation parameters for the patient. The therapy is controlled by a hand-held remote control allowing the patient to start, stop, and pause the therapy during times of sleep.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reduction in Apnea-Hypopnea Index (AHI)Time frame: 3, 6, and 12 months post implant
  2. Reduction in Oxygen Desaturation Index (ODI)Time frame: 3, 6, and 12 months post implant
  3. Freedom from Serious Adverse Events (SAE)Time frame: 1 and 12 months post implant

Locations

9 sites in 5 countries. Site status is shown where the registry gives one.

  • Sharp Rees Stealy Medical Center

    San Diego, California

  • Porter Adventist Hospital

    Denver, Colorado

  • Chicago ENT

    Chicago, Illinois

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.